We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+16.47%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.6B
AUM Growth
+$842M
Cap. Flow
-$440M
Cap. Flow %
-4.14%
Top 10 Hldgs %
16.26%
Holding
2,304
New
726
Increased
425
Reduced
494
Closed
615

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$240M
2
TMO icon
Thermo Fisher Scientific
TMO
+$151M
3
BSX icon
Boston Scientific
BSX
+$121M
4
AMZN icon
Amazon
AMZN
+$104M
5
TRU icon
TransUnion
TRU
+$81M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.87%
2 Healthcare 20.58%
3 Financials 10.9%
4 Technology 10.13%
5 Industrials 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASUR icon
726
Asure Software
ASUR
$220M
$2.07M 0.02%
339,142
-46,803
-12% -$278K
CBZ icon
727
CBIZ
CBZ
$2.29B
$2.07M 0.02%
102,116
-56,444
-36% -$1.14M
JAZZ icon
728
Jazz Pharmaceuticals
JAZZ
$15.9B
$2.05M 0.02%
14,363
+1,928
+16% +$251K
GLOB icon
729
Globant
GLOB
$1.35B
$2.05M 0.02%
+28,673
New +$1.93M
ELLI
730
DELISTED
Ellie Mae Inc
ELLI
$2.04M 0.02%
+20,718
New +$1.8M
LIND icon
731
Lindblad Expeditions
LIND
$1.76B
$2.04M 0.02%
133,642
+71,425
+115% +$971K
CX icon
732
Cemex
CX
$17.4B
$2.03M 0.02%
+437,881
New +$2.19M
CNDT icon
733
Conduent
CNDT
$230M
$2.03M 0.02%
146,769
-217,218
-60% -$2.89M
HSTM icon
734
HealthStream
HSTM
$793M
$2.03M 0.02%
72,337
-126,167
-64% -$3.32M
CCC.WS
735
DELISTED
Clarivate Analytics Plc Warrants, each to purchase one Ordinary Share
CCC.WS
$2.02M 0.02%
+599,999
New +$1.21M
KOS icon
736
Kosmos Energy
KOS
$1.56B
$2.02M 0.02%
+324,149
New +$1.8M
AROC icon
737
Archrock
AROC
$6.33B
$2.01M 0.02%
205,798
+105,372
+105% +$1.01M
GWPH
738
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2M 0.02%
11,866
+7,568
+176% +$1.13M
NWBI icon
739
Northwest Bancshares
NWBI
$2.25B
$2M 0.02%
+117,649
New +$2.09M
BKD icon
740
Brookdale Senior Living
BKD
$3.62B
$2M 0.02%
+303,185
New +$2.23M
ATR icon
741
AptarGroup
ATR
$8.45B
$1.99M 0.02%
+18,691
New +$1.87M
MYRG icon
742
MYR Group
MYRG
$5.9B
$1.97M 0.02%
+56,960
New +$1.85M
PRNB
743
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$1.97M 0.02%
57,934
+44,428
+329% +$1.41M
EGO icon
744
Eldorado Gold
EGO
$8.31B
$1.95M 0.02%
+421,467
New +$1.64M
HBAN icon
745
Huntington Bancshares
HBAN
$35.1B
$1.94M 0.02%
+152,727
New +$2.05M
VCYT icon
746
Veracyte
VCYT
$4.52B
$1.93M 0.02%
77,071
-150,653
-66% -$2.88M
QEP
747
DELISTED
QEP RESOURCES, INC.
QEP
$1.93M 0.02%
+247,343
New +$1.97M
IWM icon
748
iShares Russell 2000 ETF
IWM
$80.9B
$1.92M 0.02%
+12,547
New +$1.89M
NFLX icon
749
Netflix
NFLX
$292B
$1.92M 0.02%
53,870
+52,940
+5,692% +$1.84M
QQQ icon
750
Invesco QQQ Trust
QQQ
$455B
$1.92M 0.02%
10,693
+9,730
+1,010% +$1.65M

Similar funds

Marshall Wace's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace held 2,304 positions worth $10.6B, up 8.6% from $9.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace withdrew a net $440M in Q1 2019, closing 615 positions and reducing 494 holdings. Its most notable exit was Shire pic, an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Marshall Wace opened a new position in TransUnion worth $87.4M.

  • Marshall Wace's largest Q1 2019 buy was TransUnion: 1,307,679 shares worth $87.4M.
  • Marshall Wace added most to McDonald's in Q1 2019, an estimated $240M increase.
  • Marshall Wace's biggest Q1 2019 reduction was Alphabet (Google) Class A, cutting an estimated $132M.
  • Marshall Wace fully exited Shire pic in Q1 2019, selling an estimated $166M.
  • Marshall Wace's ten largest holdings make up 16% of its $10.6B portfolio in Q1 2019.
  • Marshall Wace opened 726 new positions and closed 615 in Q1 2019.
  • Marshall Wace's portfolio value rose 8.6% quarter-over-quarter to $10.6B.

Based on Marshall Wace's 13F filing for Q1 2019, filed 14 May 2019.